Tapentadol is partially metabolized through the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with prescription drugs that increase or repress the activity/expression of one or more of such enzymes, together with with substrates of such enzymes (resulting from competition to the enzyme); some enzyme mediators/substrates need https://nazimw107utr2.mybuzzblog.com/profile